1.
X-ray spacecraft to search for black holes
LOS ANGELES, Nov. 17 (UPI) -- Mannkind Corp. is betting that its inhalable insulin will be a hit with diabetes patients despite Pfizer's decision to stop selling a similar product.
Mannkind Chief Executive Alfred E. Mann said his inhalable insulin is medically superior to the product Pfizer pulled of the market last month because of poor sales, The Los Angeles Times reported Friday. The newspaper said Mann is putting nearly $1 billion of his own money on the effort.
"I believe this is one of the most valuable products in history in the drug industry, and I'm willing to back it up with my estate," Mann said.
MannKind, which is based in Valencia, Calif., is in the final stage of clinical trials for Technosphere Insulin. Mann said the company would be ready by the end of next year to apply for federal approval to sell the drug for Type 1 and Type 2 diabetes.
|
|
|
|
|
|
| Additional Science News Stories | |
MIAMI, May 27 (UPI) --
Tropical Storm Beryl neared hurricane strength ahead of its expected landfall Sunday night on the Southeast Coast of the United States, U.S. forecasters said.
|
'Men in Black' leads U.S. box office ... Michelle Obama, daughters see Beyonce ... Lady Gaga cancels Jakarta gig for security ... Madonna asks for pool at Israel venue ... News from United Press International.
|
CAPE CANAVERAL, Fla., May 26 (UPI) --
Astronauts aboard the International Space Station have boarded the unmanned Dragon spacecraft and began unloading supplies, NASA TV showed.
|
Wedding parties told to quiet down ... Jersey falcons put up a squawk ... Man charged in drive-through gun incident ... iCloud sends pics of suspected phone thief ... Watercooler stories from UPI.
|
| Stories | Photos | People | Comments |
View Caption
